RIVARA, Mirko
 Distribuzione geografica
Continente #
EU - Europa 1.188
NA - Nord America 1.147
AS - Asia 427
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.768
Nazione #
US - Stati Uniti d'America 1.128
CN - Cina 379
FI - Finlandia 253
SE - Svezia 239
IE - Irlanda 229
IT - Italia 162
UA - Ucraina 136
DE - Germania 89
GB - Regno Unito 33
TR - Turchia 31
CA - Canada 19
CZ - Repubblica Ceca 13
BE - Belgio 12
SG - Singapore 11
FR - Francia 6
IN - India 6
PT - Portogallo 6
NL - Olanda 4
CL - Cile 3
RU - Federazione Russa 2
AL - Albania 1
AU - Australia 1
BR - Brasile 1
EU - Europa 1
LI - Liechtenstein 1
RO - Romania 1
RS - Serbia 1
Totale 2.768
Città #
Dublin 229
Chandler 226
Jacksonville 154
Beijing 99
Ann Arbor 97
Ashburn 79
Dearborn 67
Nanjing 61
Parma 45
Princeton 45
New York 32
Wilmington 32
Izmir 31
Shanghai 30
San Mateo 29
Milan 28
Nanchang 17
Shenyang 17
Helsinki 16
Kunming 16
Guangzhou 15
Hefei 15
Jinan 15
Toronto 15
Bremen 14
Des Moines 14
Hebei 14
Los Angeles 14
Seattle 14
Brussels 12
Boardman 11
Jiaxing 11
Woodbridge 10
Brno 8
Changsha 7
Chicago 7
Piacenza 6
Tianjin 6
Auburn Hills 5
Falls Church 5
London 5
Norwalk 5
Abbiategrasso 4
Brescia 4
Chengdu 4
Düsseldorf 4
Roncadelle 4
Buccinasco 3
Castelo Branco 3
Fremont 3
Grafing 3
Gualtieri 3
Haikou 3
Hangzhou 3
Modena 3
Ningbo 3
Novi di Modena 3
Reggio Nell'emilia 3
St Andrews 3
Taiyuan 3
Taizhou 3
Trezzano Sul Naviglio 3
Vobarno 3
Wuhan 3
Zhengzhou 3
Baotou 2
Castelcovati 2
Cesena 2
Chongqing 2
Frankfurt am Main 2
Fuzhou 2
Grezzago 2
Lanzhou 2
Miami 2
Montepulciano 2
Naples 2
Oakville 2
Palermo 2
Terni 2
Torino 2
Xian 2
Alzate Brianza 1
Augusta 1
Bologna 1
Brooklyn 1
Cambridge 1
Fairfield 1
Fiorano Modenese 1
Huizen 1
Jaipur 1
Massa 1
Niles 1
Ottawa 1
Paris 1
Phoenix 1
Porto San Giorgio 1
Pune 1
Quzhou 1
Redwood City 1
Rockville 1
Totale 1.703
Nome #
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 92
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 88
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 83
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 81
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 80
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 76
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 76
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 74
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 73
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 72
Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain 71
Antioxidant and cytoprotective activity of indole derivatives related to melatonin 71
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 71
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 70
Chiral NMR discrimination of the diastereoisomeric salts of the H(3)-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazole. 70
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 70
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 70
Drug repurposing approaches to fight Dengue virus infection and related diseases 69
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 68
Advances in Design and Development of Sodium Channel Blockers. 67
2,4(5)-Diarylimidazoles: Synthesis and Biological Evaluation of a New Class of Sodium Channel Blockers against hNav1.2 65
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 65
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 63
NMR Analysis of a Series of Imidazobenzoxazines 61
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 61
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 60
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry 59
Sodium Channel Blocking Activity and In-vivo Testing of New Phenyl-imidazole Derivatives. 56
Gene-Delivery Ability of New Hydrogenated and Partially Fluorinated Gemini bispyridinium Surfactants with Six Methylene Spacers 55
Anticonvulsant Activity of 2,4(5)-Diarylimidazoles in Mice and Rat Models 54
2,4(5)-Diarylimidazoles as Inhibitors of hNaV1.2 Sodium Channels: Pharmacological Evaluationand Structure-Property Relationships 53
Biological evaluation of imidazobenzoxazines, imidazobenzoxazin-5-ones and imidazobenzoxazin-5-thiones as sodium channel blockers 53
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 53
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 51
Sodium channel blockers: a patent review (2010 - 2014) 51
Anticonvulsant Activity of 2,4(1H)-Diarylimidazoles in Mice and Rats Acute Seizure Models 49
Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates 49
A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks 48
Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential 46
In vivo Screening of Diarylimidazoles as Anticonvulsant Agents 46
Sodium channel blockers for neuropathic pain. 42
Microwave Assisted Efficient Synthesis of Imidazole-based Privileged Structure 40
NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet syndrome 37
Chemico-Physical Properties of Some 1,1′-Bis-alkyl-2,2′-hexane-1,6-diyl-bispyridinium Chlorides Hydrogenated and Partially Fluorinated for Gene Delivery 35
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 32
Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release 28
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 25
Totale 2.829
Categoria #
all - tutte 10.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.089


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201950 0 0 0 0 0 0 0 0 0 0 49 1
2019/2020600 83 90 35 7 46 52 92 16 55 70 11 43
2020/2021304 11 39 24 16 31 9 47 10 55 16 42 4
2021/2022229 3 2 5 18 14 7 29 26 21 17 17 70
2022/2023929 106 108 68 57 71 118 17 44 275 12 36 17
2023/2024314 22 32 11 14 43 84 38 29 19 21 1 0
Totale 2.829